Evidence-based Complementary and Alternative Medicine · 2022 · 10 citations · 25 references
MedicineNephrologyPharmacologyApoptosisChemotherapyRenal PathophysiologyChronic Kidney DiseaseNephrotoxicity MechanismsRenal DiseaseRenal PharmacologyRenal ToxicityApoptosis In Renal ToxicityChemotherapy-associated NephrotoxicityDrug-induced Acute Kidney InjuryPro-apoptotic AgentsPro-apoptotic Bax ActivationPro-apoptotic ProteinsRenal ApoptosisTraditional Chinese Medicine
Cisplatin, also known as cis-diamine dichloroplatinum (CDDP), is a widely used chemotherapeutic drug. However, its application is limited by the occurrence of serious nephrotoxicity. Currently, no effective therapy is available for combating CDDP-induced acute kidney injury (AKI). In the present study, we investigated the efficacy of Jianpi Yishen Tang (JPYST), a traditional Chinese medicine (TCM) compound commonly used to treat chronic kidney disease, against CDDP-induced AKI. In the CDDP + JPYST group, male mice were pretreated with JPYST (18.35 g/kg/day) for 5 consecutive days before receiving a single dose of CDDP (20 mg/kg), all mice were sacrificed 72 h after the CDDP injection. Results showed that JPYST suppressed CDDP-induced kidney dysfunction and tubular damage scores in the mice. Mechanistically, JPYST treatment attenuated CDDP-induced renal tubular cell apoptosis in AKI mice, as manifested by a marked decreased in TUNEL-positive cell counts, downregulation of the pro-apoptotic proteins Bax, Bad and caspase 3, and upregulation of the antiapoptotic protein Bcl-2 in kidney tissues. Meanwhile, JPYST decreased the expression of inflammatory cytokines TNF-α, IL-1β, and IL-6 in the serum and renal tissues of mice following CDDP administration. These factors are involved in suppressing the activation of phospho-NF-κB p65 in tubular epithelial cells. Taken together, these findings demonstrated that JPYST exerts renoprotective effects against CDDP-induced AKI through antiapoptosis and anti-inflammation effects, and these are associated with downregulation of NF-κB activation. Therefore, JPYST has potential for development of treatment therapies against CDDP-induced AKI.
25
The pathological role of Bax in cisplatin nephrotoxicity
Qingqing Wei, Guie Dong, James L. Franklin et al. · Kidney International · 2007 · 227 citations
Medicine, Nephrology, Toxicology +13
NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI)
Abdullah Özkök, Kameswaran Ravichandran, Qian Wang et al. · Toxicology Letters · 2015 · 108 citations
Medicine, Nephrology, Oncology +14